SCHEMBL28024865

SCHEMBL28024865

CSCCc1c[nH]nc1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.37
DCUN1D1 Q96GG9 3/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
GFER P55789 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
TTK P33981 2/20 0.33
HTR7 P34969 1/20 0.33
ALPL P05186 2/20 0.33
IDO1 P14902 1/20 0.33
MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11624564 0.81 ALOX15 (0.41) ALOX15ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL28025288 0.79 ALOX15 (0.38) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL20449061 0.78 TAAR1 (0.41) ALOX15ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL11123121 0.78 ALOX15 (0.43) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL5584092 0.77 GPR84 (0.49) ALOX15ALDH1A1MAPTNPSR1
SCHEMBL14036889 0.75 KDM4E (0.44) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL14094653 0.75 RIPK1 (0.42) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL18901018 0.74 DPP4 (0.44) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL28861332 0.74 ALOX15 (0.43) ALOX15ALDH1A1KDM4EHPGDLMNA
SCHEMBL28583866 0.74 ALOX15 (0.43) ALOX15ALDH1A1KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102292321-B Pyrazolyl-substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor for the treatment of receptor-related disorders ARENA PHARMACEUTICALS, INC. (US) 2015-08-12 CN disclosed